UCN-01 (7-Hydroxystaurosporine) to Treat Relapsed T-Cell Lymphomas
BENdamustine at Elevated Dose for Relapsed Follicular Lymphoma in Intensification Therapy and Transplantation (BENEFIT)
Dasatinib in Relapsed or Refractory Non-Hodgkin's Lymphoma
"MIRO" Molecularly Oriented Immuno-radio-therapy
T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma
† Study has passed its completion date and status has not been verified in more than two years.